Do treatments for age-related macular degeneration (AMD) work for PXE eye problems?
Although there are some similarities between AMD and PXE in the eye, and often the same treatments are offered for both, ophthalmologists and retinologists caution their PXE patients that PXE has a different cause and a different process. PXE does not respond to treatment in exactly the same way. Individuals affected by PXE may benefit from treatments that are often used for AMD. PXE is extremely variable, and even the experience of one PXE patient may be of little help in predicting results for another. This is partly because as yet we do not have PXE clinical trials to draw on for conclusions about what works best, and for whom. [September 2006] RETURN TO TOP 2. Are Macugen treatments, approved for use in people with wet AMD, an option for PXE? On December 18, 2004, the U.S. Food and Drug Administration approved the use of Macugen as a new therapy to slow vision loss in people with neovascular (wet) age-related macular degeneration (AMD). Treatments require injections into the eye ap
